FULC Stock Analysis: Buy, Sell, or Hold?
FULC - Fulcrum Therapeutics, Inc. Common Stock
$3.47
-0.04 (-1.00%)
▼
5d:
-2.39%
30d:
-41.37%
90d:
-50.78%
BUY
HIGH Confidence
Analysis Updated: Jun 17, 2026 12:00 AM ET
Earnings: Aug 04, 2026
Get Alerted When FULC Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: FULC shows strong fundamentals and good volume confirmation. Solid entry point despite oversold pricing.
✅ BUY SIGNAL: FULC shows strong fundamentals and good volume confirmation. Solid entry point despite oversold pricing.
In-depth Analysis How we analyze
Valuation Analysis: FULC is currently trading at $3.46, which is considered oversold relative to its 30-day fair value range of $3.61 to $6.88.
Technical Outlook: Technically, FULC is in a strong downtrend. Immediate support is located at $3.21, while resistance sits at $3.70.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $6.62 (+89.3%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, FULC is in a strong downtrend. Immediate support is located at $3.21, while resistance sits at $3.70.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $6.62 (+89.3%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$3.61 -
$6.88
Company Quality Score
57/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
82.6%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 89.3% below Wall St target ($6.62)
Trading Range Analysis
30-Day Trading Range
$3.61 -
$6.88
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$3.21
Resistance Level
$3.70
Current Trend
Strong Downtrend
Technical data as of
Jun 17, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-5.32
Wall Street Target
$6.63
(+89.3%)
Revenue Growth (YoY)
-100.0%
Share & Embed Analysis
Last updated: June 18, 2026 11:22 AM ET
Data refreshes hourly during market hours. Next update: 12:22 PM
Data refreshes hourly during market hours. Next update: 12:22 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is FULC showing a specific setup today?
Insider Activity (6 Months)
0
Buys
1
Sells
Net
INSIDERS SELLING
Recent Transactions
Robert J Gould
SELL
15000 shares
2026-01-02
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
SRPT
Sarepta Therapeutics Inc |
STRONG BUY
26 analysts |
$22 | 54 HOLD |
|
NRIX
Nurix Therapeutics Inc |
STRONG BUY
18 analysts |
$31 | 59 HOLD |
|
BNTX
BioNTech SE |
STRONG BUY
21 analysts |
$123 | 53 HOLD |
|
DYN
Dyne Therapeutics Inc |
STRONG BUY
14 analysts |
$38 | 61 BUY |
|
DNTH
Dianthus Therapeutics In… |
STRONG BUY
12 analysts |
$128 | 54 HOLD |
Advanced FULC Option Strategies
Professional options setups generated by AI based on today's FULC price and gamma walls.
